VTU bringing advanced protein expression to key European conferences

Grambach, Austria: – VTU Technology´s Head of Business Development Dr. Thomas Purkarthofer will represent VTU at two key summit meetings in Vienna and Stockholm during April.

At both events, he will be able to provide detailed information on VTU´s next generation protein expression technologies and advanced toolbox that have enabled VTU to achieve the highest protein expression productivities ever reported for Pichia pastoris – up to 35 grams per liter.

BIO-Europe Spring, Stockholm

Dr. Purkarthofer will first travel to the Swedish capital, Stockholm for the BIO-Europe Spring conference, where he will use the event’s online partnering system to arrange a series of meetings throughout the three-day event. He is hoping to discuss technology transfers and out licensing opportunities for products including e.g. Human Serum Albumin (HSA), Human Serum Transferrin (HST), HSA-fusion proteins, cell culture proteins and others.

“We’re reaching out pharmaceutical and veterinary companies, food, chemical and biotechnology companies with the potential to exploit and benefit from our versatile Pichia pastoris technology platform,” said Dr. Purkarthofer.

BioProcess International, Vienna

Five days after BIO-Europe Spring closes, Dr. Purkarthofer will travel on to Vienna, Austria, to attend the BioProcess International European Summit, to provide delegates with insights into VTU´s latest technology developments.

He will be able to unveil details of VTU’s latest achievements in developing its world-leading Pichia pastoris recombinant platform. The four-day event, billed as Europe’s Largest Bioprocessing Conference, will involve more than 450 Bioprocessing Decision Makers from some 230 Companies, including nine out of the Top 10 global biopharma players.

Dr. Purkarthofer is accepting appointments for face-to-face meetings at both events. Those wishing to meet him should email him directly at [email protected]

About VTU Technology

VTU Technology is a leading service provider for the fast track development of protein expression strains and protein production processes often yielding up to 25 g/L of secreted protein (recently reaching 35 g/l of secreted protein) for a wide range of biologics and other proteins.

VTU Technology´s powerful Pichia pastoris protein expression technology suite, an in-house expression platform which is continuously updated and expanded, is mainly based on its exclusive AOX1 promoter libraries and complemented by its optimized gene design and cloning strategies as well as high-throughput screening and cultivation regime, combined with excellent know-how in fermentation and downstream process development.

Headquartered in Grambach, near Graz, Austria, VTU Technology is a private company and a subsidiary of VTU Holding, an Austrian enterprise that combines several technology and engineering companies in pharma and life sciences, chemistry and energy.

About BIOEurope Spring 2016

BIO-Europe Spring® a premier partnering conference that annually attracts an international “who’s who” from biotech, pharma and finance for high caliber networking.

The three-day event, held at Stockholm’s Kistamässan Convention Center, opens on April 3.
Featuring EBD Group’s partnering system, partneringONE®, the event enables delegates to network with companies across the life science value chain, from large biotech and pharma companies to financiers and innovators.

The conference is expected to attract more than 2,300 delegates and 68 exhibitors from more than 50 countries worldwide, featuring more than 20 workshops and panels with more than 6,600 licensing opportunities posted.

The event is organized by EBD with more information at: http://www.ebdgroup.com/bes/index.php

About BioProcess International 2016

Now in its 12th year, the BioProcess International European Summit will host more than 400 bioprocessing professionals from academia and industry.

The conference features four major streams on Cell Culture & Upstream Processing, Downstream Processing, Manufacturing & Continuous Processing and Cell Line Development, along with numerous keynote speeches poster presentations, and an exhibition: all part of the conference’s mission to connect the biopharmaceutical industry with new ideas and innovations across all phases of bioprocess development.

The four-day event opens April 11 at Reed Messe Wien Congress Center, Vienna.
Informa organizes the event with more information at: http://www.informa-ls.com/event/BPI2016